BRENNTAG SE NA O.N./ DE000A1DAHH0 /
| 13/05/2024 14:00:00 | Var. +0.08 | Volume | Denaro14:00:46 | Lettera14:00:29 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
|---|---|---|---|---|---|---|---|
| 77.82EUR | +0.10% | 36,664 Fatturato: 2.86 mill. |
77.82Quantità in denaro: 64 | 77.84Quantità in lettera: 73 | 11.76 bill.EUR | 2.70% | 16.46 |
GlobeNewswire
14:15
Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of ...
GlobeNewswire
14:15
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update
GlobeNewswire
14:05
Company Name Change to NAPC Defense, Inc. (OTCPK: BLIS) and Website to NAPCDefense.com among Busines...
GlobeNewswire
14:05
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
GlobeNewswire
14:05
Cheetah Net Supply Chain Service Inc. Announces 1st Quarter 2024 Results and Provides Corporate Upda...
GlobeNewswire
14:03
Tango Launches Global Choice Link, making it easy and awesome for businesses to deliver rewards, inc...
GlobeNewswire
14:02
CSW Industrials Announces Date for Fiscal Fourth Quarter and Full Year 2024 Earnings Release Confere...
GlobeNewswire
14:01
SecureW2 Wins Digital Certificate, Network Security, and Passwordless Solution Categories in 2024 Cy...
GlobeNewswire
14:00
SOUTHERN CALIFORNIA BANCORP AND CALIFORNIA BANCORP ANNOUNCE RECEIPT OF REGULATORY APPROVAL FOR MERGE...
GlobeNewswire
14:00
X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire
14:00
Great Pacific Gold Reports Multiple High-Grade Gold Assays from Kesar Creek Project in Papua New Gui...
GlobeNewswire
14:00
IN8bio Demonstrates Robust and Reproducible Gamma-Delta T Cell Therapy Manufacturing in Oral Present...
GlobeNewswire
14:00
Exagen Inc. Reports Strong First Quarter 2024 Results: Raises Guidance for Full Year
